ES2075107T3 - Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion. - Google Patents

Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion.

Info

Publication number
ES2075107T3
ES2075107T3 ES90119087T ES90119087T ES2075107T3 ES 2075107 T3 ES2075107 T3 ES 2075107T3 ES 90119087 T ES90119087 T ES 90119087T ES 90119087 T ES90119087 T ES 90119087T ES 2075107 T3 ES2075107 T3 ES 2075107T3
Authority
ES
Spain
Prior art keywords
ibuprofen
procedure
preparation
compositions containing
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90119087T
Other languages
English (en)
Inventor
K Prof Dr Chem Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmatrans Sanaq AG
Original Assignee
Pharmatrans Sanaq AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmatrans Sanaq AG filed Critical Pharmatrans Sanaq AG
Application granted granted Critical
Publication of ES2075107T3 publication Critical patent/ES2075107T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UNA PREPARACION QUE CONTIENE IBUPROFENO Y/O S-(+)-IBUPROFENO Y ADITIVOS Y PORTADORES NORMALES, ASI COMO SU DISPOSICION EN TABLETAS. EL PROCEDIMIENTO PARA SU PREPARACION SE CARACTERIZA PORQUE CONTIENE SAL DE IBUPROFENO DE CALCIO Y/O SAL DE S-(+)-IBUPROFENO DE CALCIO.
ES90119087T 1989-07-07 1990-10-05 Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion. Expired - Lifetime ES2075107T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3922441A DE3922441A1 (de) 1989-07-07 1989-07-07 Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES2075107T3 true ES2075107T3 (es) 1995-10-01

Family

ID=6384536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90119087T Expired - Lifetime ES2075107T3 (es) 1989-07-07 1990-10-05 Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion.

Country Status (6)

Country Link
EP (1) EP0478838B1 (es)
AT (1) ATE125700T1 (es)
DE (2) DE3922441A1 (es)
DK (1) DK0478838T3 (es)
ES (1) ES2075107T3 (es)
GR (1) GR3017042T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2148175T3 (es) 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
DK0607467T3 (da) * 1992-12-01 1999-12-13 Spirig Ag Lægemidler, der indeholder S(+)-ibuprofen
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP2559430B1 (en) 2005-03-22 2015-06-24 Losan Pharma GmbH Solubilized Ibuprofen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935359A1 (de) * 1979-09-01 1981-03-26 Basf Ag, 67063 Ludwigshafen 6-imidazolyl-3-hydrazino-pyridazine
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
GB8716975D0 (en) * 1987-07-17 1987-08-26 Boots Co Plc Therapeutic agents
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
DE59009479D1 (de) 1995-09-07
EP0478838A1 (de) 1992-04-08
EP0478838B1 (de) 1995-08-02
GR3017042T3 (en) 1995-11-30
DE3922441A1 (de) 1991-01-17
ATE125700T1 (de) 1995-08-15
DK0478838T3 (da) 1995-09-18

Similar Documents

Publication Publication Date Title
PT91501A (pt) Processo para a preparacao de uma composicao que inclui complexos hospedeiros/ hospedes que formam cavitatos ou clatratos como agentes de contraste
PT89709A (pt) Processo para a preparacao de uma composicao que inibe a formacao vegetativa marinha
ES534098A0 (es) Procedimiento para la obtencion de eglinas b o c modificadas
BR8807416A (pt) Processo para preparar uma composicao sulfurada,concentrado de aditivo para uso na preparacao de composicoes lubrificantes e composicao lubrificante
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
FI880629A (fi) Fosfopeptidejä, niiden valmistusmenetelmä ja käyttö sekä niitä sisältäviä suunhuoltokoostumuksia
ES2061740T3 (es) Estabilizacion de masas de organopolisiloxanos reticulables para formar elastomeros con separacion de alcoholes.
GB2192131B (en) Pharmaceutical compositions containing calcium salts.
ES550042A0 (es) Un procedimiento para preparar mono-olefinas alifaticas que tienen 4-24 atomos de carbono por molecula.
AU1530088A (en) Conditioning liquids for tooth or bone matter
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
SE8303696D0 (sv) Farmakologiska kompositioner
MX9204031A (es) Sal de l-ascorbato de 16-descarboxi-16-hidroximetil-amfotericina b, proceso para su preparacion y composicion farmaceutica que contiene dicha sal.
ES2075107T3 (es) Composiciones que contienen ibuprofeno y s(+)-ibuprofeno, y procedimiento para su preparacion.
DE3888036D1 (de) Optisch aktive Verbindung, Verfahren zur ihrer Herstellung und sie enthaltende flüssigkristalline Zusammensetzung.
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
FI884195A0 (fi) Olennaisesti puhdasta kalsiummagnesiumasetaattikaksoissuolaa sisältäviä jäänpoistokoostumuksia sekä menetelmiä niiden valmistamiseksi
AU623805B2 (en) New use of anti-progestomimetic compounds
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
DE69016065T2 (de) Verfahren zur Herstellung von Calciumsalzen von Fettsäuren.
PT92228A (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas
DE69114635D1 (de) 1,3-Diphenyl-2-propin-1-one.
UA37211C2 (uk) Похідні 1,4-дигідропіридину у формі рацемату або енантіомерів, 2-хлор-3-ціанобензальдегід як проміжний продукт для їх одержання та фармацевтична композиція, що має антагоністичну активність по відношенню до катіонів кальцію
ATE79539T1 (de) Pharmazeutische zusammensetzung enthaltend 1isopropyldihydrolysergsaeure.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 478838

Country of ref document: ES